Impax Asset Management Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.1M Sell
396,513
-41,955
-10% -$5.15M 0.35% 63
2026
Q1
$51.7M Buy
438,468
+25,084
+6% +$3.5M 0.36% 70
2025
Q4
$67.7M Sell
413,384
-289,853
-41% -$45.4M 0.42% 69
2025
Q3
$93M Sell
703,237
-57,806
-8% -$7.02M 0.54% 60
2025
Q2
$93.8M Sell
761,043
-43,468
-5% -$5.53M 0.54% 61
2025
Q1
$101M Sell
804,511
-247,428
-24% -$38.1M 0.61% 55
2024
Q4
$150M Sell
1,051,939
-6,230
-0.6% -$893K 0.68% 56
2024
Q3
$156M Sell
1,058,169
-68,709
-6% -$9.85M 0.62% 57
2024
Q2
$141M Buy
1,126,878
+445,858
+65% +$69.9M 0.57% 58
2024
Q1
$125M Sell
681,020
-231,801
-25% -$44.1M 0.48% 70
2023
Q4
$163M Sell
912,821
-59,848
-6% -$9.32M 0.66% 55
2023
Q3
$154M Sell
972,669
-39,398
-4% -$6.44M 0.69% 51
2023
Q2
$142M Buy
1,012,067
+145,688
+17% +$23.4M 0.57% 61
2023
Q1
$145M Buy
866,379
+45,527
+6% +$8.12M 0.61% 59
2022
Q4
$138M Buy
820,852
+66,751
+9% +$12.1M 0.62% 59
2022
Q3
$140M Sell
754,101
-96,050
-11% -$20.3M 0.72% 54
2022
Q2
$137M Sell
850,151
-43,160
-5% -$6.83M 0.67% 58
2022
Q1
$167M Buy
893,311
+80,299
+10% +$15.3M 0.69% 57
2021
Q4
$214M Buy
813,012
+195,300
+32% +$52.6M 0.78% 49
2021
Q3
$178M Sell
617,712
-198,804
-24% -$51M 0.73% 55
2021
Q2
$162M Buy
816,516
+50,362
+7% +$9.77M 0.72% 51
2021
Q1
$148M Buy
766,154
+205,306
+37% +$42.1M 0.76% 52
2020
Q4
$107M Buy
560,848
+275,711
+97% +$50.2M 0.68% 57
2020
Q3
$41.6M Sell
285,137
-3,459
-1% -$494K 0.36% 66
2020
Q2
$35.7M Buy
288,596
+125,496
+77% +$14.8M 0.37% 66
2020
Q1
$15.6M Buy
+163,100
New +$15.7M 0.21% 89

Other funds holding RGEN

Impax Asset Management Group's RGEN Position: Q2 2026 in Review

Impax Asset Management Group reduced its Repligen (RGEN) stake by 9.6% in Q2 2026, selling an estimated $5.15M and leaving 396,513 shares worth $54.1M. The position accounts for 0.35% of the portfolio, ranked #63.

Impax Asset Management Group first reported a position in RGEN in Q1 2020 and has held it in 26 quarters since. The position peaked at $214M in Q4 2021. 343 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Impax Asset Management Group held 396,513 shares of Repligen worth $54.1M as of Q2 2026.
  • Impax Asset Management Group sold 41,955 Repligen shares in Q2 2026, an estimated $5.15M.
  • Repligen made up 0.35% of Impax Asset Management Group's portfolio in Q2 2026, its #63 holding.
  • Impax Asset Management Group first reported a position in Repligen in Q1 2020 and has held it in 26 quarters since.
  • Impax Asset Management Group's Repligen position peaked at $214M in Q4 2021.
  • 343 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Impax Asset Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.